Graf C, Battisti WP, Bridges D, Bruce-Winkler V, Conaty JM, Ellison JM, Field EA, Gurr JA, Marx ME, Patel M, Sanes-Miller C, Yarker YE; International Society for Medical Publication Professionals. Research Methods & Reporting. Good publication practice for communicating company sponsored medical research: the GPP2 guidelines. BMJ 2009 Nov 27;339:b4330. doi: 10.1136/bmj.b4330
Good Publication Practice 2 (GPP2) represents an useful document for the publication of company-sponsored medical research. Commissioned by the International Society for Medical Publication Professionals (ISMPP) and developed by a recruited steering committee, GPP2 is an update of the original GPP guidelines published in 2003. The document is mostly based on the recommendations of codes of practice developed by international associations, like COPE, WAME or CSE, but it takes into account also the publisher’s prospective (Elsevier and Wiley-Blackwell) and the prospective of Pharmaceutical Companies. From authorship to conflicts of interest, the document provides recommendation for both articles and presentations. An interesting section concerns publication planning, to ensure that clinical trials results are communicated to the medical and scientific community in an effective and timely manner.
Good Publication Practice 2 (GPP2) represents an useful document for the publication of company-sponsored medical research. Commissioned by the International Society for Medical Publication Professionals (ISMPP) and developed by a recruited steering committee, GPP2 is an update of the original GPP guidelines published in 2003. The document is mostly based on the recommendations of codes of practice developed by international associations, like COPE, WAME or CSE, but it takes into account also the publisher’s prospective (Elsevier and Wiley-Blackwell) and the prospective of Pharmaceutical Companies. From authorship to conflicts of interest, the document provides recommendation for both articles and presentations. An interesting section concerns publication planning, to ensure that clinical trials results are communicated to the medical and scientific community in an effective and timely manner.
Comments